Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Cahill

Showing results (21-30 of 196) with videos related to

Pageof 20
Sort By:
Neurosurgical Focus|March 3, 2015
Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case seriesPamela S Jones, Daniel P Cahill, Priscilla K Brastianos, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?Martin C Tom, Daniel P Cahill, Jan C Buckner, et al.
Journal of Neuro-Oncology|July 19, 2012
Butterfly glioblastomas: a retrospective review and qualitative assessment of outcomesKristine Dziurzynski, David Blas-Boria, Dima Suki, et al.
Journal of Magnetic Resonance Open|December 4, 2023
Inductively coupled, transmit-receive coils for proton MRI and X-nucleus MRI/MRS in small animalsAtsushi M Takahashi, Jitendra Sharma, David O Guarin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistanceStephen Yip, Jiangyong Miao, Daniel P Cahill, et al.
Neurosurgical Focus|December 2, 2016
Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapyJuan Carlos Martinez-Gutierrez, Megan R D'Andrea, Daniel P Cahill, et al.
Neurosurgical Focus|February 5, 2013
Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th annual Frye-Halloran Brain Tumor SymposiumPamela S Jones, Gavin P Dunn, Fred G Barker, et al.
Cancer|November 15, 2019
Neurologic complications of melanomaJustine V Cohen, Nancy Wang, Vyshak A Venur, et al.
Molecular Cancer Therapeutics|September 16, 2018
PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to TemozolomideFumi Higuchi, Alexandria L Fink, Juri Kiyokawa, et al.
Neuro-Oncology Advances|March 30, 2026
Effects of short- and long-term mutant IDH1 inhibition on radiosensitivity across genetically diverse patient-derived IDH1-mutant glioma cellsYosuke Kitagawa, Logan D Muzyka, Ami Kobayashi, et al.
Pageof 20

Showing results (21-30 of 196) with videos related to

Sort By:
Pageof 20
Neurosurgical Focus|March 3, 2015
Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case seriesPamela S Jones, Daniel P Cahill, Priscilla K Brastianos, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Management for Different Glioma Subtypes: Are All Low-Grade Gliomas Created Equal?Martin C Tom, Daniel P Cahill, Jan C Buckner, et al.
Journal of Neuro-Oncology|July 19, 2012
Butterfly glioblastomas: a retrospective review and qualitative assessment of outcomesKristine Dziurzynski, David Blas-Boria, Dima Suki, et al.
Journal of Magnetic Resonance Open|December 4, 2023
Inductively coupled, transmit-receive coils for proton MRI and X-nucleus MRI/MRS in small animalsAtsushi M Takahashi, Jitendra Sharma, David O Guarin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistanceStephen Yip, Jiangyong Miao, Daniel P Cahill, et al.
Neurosurgical Focus|December 2, 2016
Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapyJuan Carlos Martinez-Gutierrez, Megan R D'Andrea, Daniel P Cahill, et al.
Neurosurgical Focus|February 5, 2013
Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th annual Frye-Halloran Brain Tumor SymposiumPamela S Jones, Gavin P Dunn, Fred G Barker, et al.
Cancer|November 15, 2019
Neurologic complications of melanomaJustine V Cohen, Nancy Wang, Vyshak A Venur, et al.
Molecular Cancer Therapeutics|September 16, 2018
PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to TemozolomideFumi Higuchi, Alexandria L Fink, Juri Kiyokawa, et al.
Neuro-Oncology Advances|March 30, 2026
Effects of short- and long-term mutant IDH1 inhibition on radiosensitivity across genetically diverse patient-derived IDH1-mutant glioma cellsYosuke Kitagawa, Logan D Muzyka, Ami Kobayashi, et al.
Pageof 20